Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 3
1986 3
1987 3
1988 8
1989 9
1990 6
1991 4
1992 6
1993 4
1994 3
1995 6
1996 8
1998 4
1999 11
2000 8
2001 2
2002 6
2003 10
2004 7
2005 6
2006 8
2007 7
2008 7
2009 3
2010 5
2011 8
2012 12
2013 9
2014 11
2015 11
2016 10
2017 6
2018 7
2019 8
2020 5
2021 4
2022 5
2023 6
2024 2
2025 5
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

240 results

Results by year

Filters applied: . Clear all
Page 1
Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial.
Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Heim L, Gombosev A, Avery TR, Haffenreffer K, Shimelman L, Hayden MK, Weinstein RA, Spencer-Smith C, Kaganov RE, Murphy MV, Forehand T, Lankiewicz J, Coady MH, Portillo L, Sarup-Patel J, Jernigan JA, Perlin JB, Platt R; ABATE Infection trial team. Huang SS, et al. Lancet. 2019 Mar 23;393(10177):1205-1215. doi: 10.1016/S0140-6736(18)32593-5. Epub 2019 Mar 5. Lancet. 2019. PMID: 30850112 Free PMC article. Clinical Trial.
METHODS: The ABATE Infection (active bathing to eliminate infection) trial was a cluster-randomised trial of 53 hospitals comparing routine bathing to decolonisation with universal chlorhexidine and targeted nasal mupirocin in non-critical-care units. The trial was done in …
METHODS: The ABATE Infection (active bathing to eliminate infection) trial was a cluster-randomised trial of 53 hospitals comparing routine …
Bacterial Decolonization for Prevention of Radiation Dermatitis: A Randomized Clinical Trial.
Kost Y, Deutsch A, Mieczkowska K, Nazarian R, Muskat A, Hosgood HD, Lin J, Daily JP, Ohri N, Kabarriti R, Shinoda K, McLellan BN. Kost Y, et al. JAMA Oncol. 2023 Jul 1;9(7):940-945. doi: 10.1001/jamaoncol.2023.0444. JAMA Oncol. 2023. PMID: 37140904 Free PMC article. Clinical Trial.
Analysis was performed on January 7, 2022. INTERVENTIONS: Intranasal mupirocin ointment twice daily and chlorhexidine body cleanser once daily for 5 days prior to RT and repeated for 5 days every 2 weeks through RT. ...
Analysis was performed on January 7, 2022. INTERVENTIONS: Intranasal mupirocin ointment twice daily and chlorhexidine body cleanser o …
Bacterial Decolonization With Mupirocin Ointment for Acute Radiation Oral Mucositis Prevention: A Phase 3 Randomized Clinical Trial.
Liao Z, Xiong X, Zhao L, Zhang Z, Guan C, Zhang L, Zhong F, Rao J, Wang X, Xiao Y, Gong X, Huang SH, Li J, Lu T. Liao Z, et al. JAMA Oncol. 2025 Oct 1;11(10):1141-1149. doi: 10.1001/jamaoncol.2025.2361. JAMA Oncol. 2025. PMID: 40773220 Free PMC article. Clinical Trial.
OBJECTIVE: To evaluate the efficacy of BD with mupirocin nasal ointment in alleviating severe AROM compared with standard of care (SoC) by reducing Staphylococcus aureus colonization in nasal and oral mucosal during radiotherapy for nasopharyngeal cancer. ...Data were anal …
OBJECTIVE: To evaluate the efficacy of BD with mupirocin nasal ointment in alleviating severe AROM compared with standard of care (So …
Impetigo.
Esterly NB, Nelson DB, Dunne WM Jr. Esterly NB, et al. Am J Dis Child. 1991 Feb;145(2):125-6. doi: 10.1001/archpedi.1991.02160020015003. Am J Dis Child. 1991. PMID: 1899777 Clinical Trial. No abstract available.
Nasal Iodophor Antiseptic vs Nasal Mupirocin Antibiotic in the Setting of Chlorhexidine Bathing to Prevent Infections in Adult ICUs: A Randomized Clinical Trial.
Huang SS, Septimus EJ, Kleinman K, Heim LT, Moody JA, Avery TR, McLean L, Rashid S, Haffenreffer K, Shimelman L, Staub-Juergens W, Spencer-Smith C, Sljivo S, Rosen E, Poland RE, Coady MH, Lee CH, Blanchard EJ, Reddish K, Hayden MK, Weinstein RA, Carver B, Smith K, Hickok J, Lolans K, Khan N, Sturdevant SG, Reddy SC, Jernigan JA, Sands KE, Perlin JB, Platt R. Huang SS, et al. JAMA. 2023 Oct 10;330(14):1337-1347. doi: 10.1001/jama.2023.17219. JAMA. 2023. PMID: 37815567 Free PMC article. Clinical Trial.
Antibiotic resistance to mupirocin has raised questions about whether an antiseptic could be advantageous for ICU decolonization. ...For MRSA clinical cultures, HRs were 1.13 for iodophor-CHG (raw rate: 2.3 vs 2.1/1000 ICU-attributable days) and 0.99 for mupirocin-C …
Antibiotic resistance to mupirocin has raised questions about whether an antiseptic could be advantageous for ICU decolonization. ... …
The clinical development of mupirocin.
Pappa KA. Pappa KA. J Am Acad Dermatol. 1990 May;22(5 Pt 1):873-9. doi: 10.1016/0190-9622(90)70116-y. J Am Acad Dermatol. 1990. PMID: 2112164 Review.
Mupirocin is a novel antibiotic totally unrelated in chemical structure and mode of action to any other clinically useful class of antibiotics. ...Randomized, multicenter, double-blind, vehicle-controlled clinical trials have shown that mupirocin is safe and effecti …
Mupirocin is a novel antibiotic totally unrelated in chemical structure and mode of action to any other clinically useful class of an …
Comparison of global decolonization efficacy with mupirocin nasal drop and chlorhexidine mouthwash in acute leukemia patients: randomized clinical trial.
Ghaffary S, Javidnia A, Beheshtirouy S, Sadeghi J, Akbari AM, Hamishehkar H, Sarbakhsh P, Sanaat Z, Nikanfar A, Esfahani A, Chavoshi SH, Nejati B, Raeisi M, Gholami N. Ghaffary S, et al. Support Care Cancer. 2023 Dec 19;32(1):42. doi: 10.1007/s00520-023-08232-1. Support Care Cancer. 2023. PMID: 38110726 Clinical Trial.
RESULTS: Bacterial recovery of both nasal and pharynx swabs was observed after global decolonization with mupirocin nasal drop. Decolonization with mupirocin significantly eradicated Coagulase-negative staphylococci (CONS) in both nasal and pharynx swabs (p-value = …
RESULTS: Bacterial recovery of both nasal and pharynx swabs was observed after global decolonization with mupirocin nasal drop. Decol …
Mupirocin: a topical antibiotic with a unique structure and mechanism of action.
Parenti MA, Hatfield SM, Leyden JJ. Parenti MA, et al. Clin Pharm. 1987 Oct;6(10):761-70. Clin Pharm. 1987. PMID: 3146455 Review.
Mupirocin (Bactroban, Beecham Laboratories) is currently formulated as a 2% ointment in a water-miscible polyethylene glycol base. ...Mupirocin should be useful for treating patients with impetigo and wound infections caused by Staphylococcus aureus. ...
Mupirocin (Bactroban, Beecham Laboratories) is currently formulated as a 2% ointment in a water-miscible polyethylene glycol base. .. …
Chlorhexidine and Mupirocin Susceptibility of Methicillin-Resistant Staphylococcus aureus Isolates in the REDUCE-MRSA Trial.
Hayden MK, Lolans K, Haffenreffer K, Avery TR, Kleinman K, Li H, Kaganov RE, Lankiewicz J, Moody J, Septimus E, Weinstein RA, Hickok J, Jernigan J, Perlin JB, Platt R, Huang SS. Hayden MK, et al. J Clin Microbiol. 2016 Nov;54(11):2735-2742. doi: 10.1128/JCM.01444-16. Epub 2016 Aug 24. J Clin Microbiol. 2016. PMID: 27558180 Free PMC article. Clinical Trial.
REDUCE-MRSA was a 3-arm, cluster-randomized trial of either screening and isolation without decolonization, targeted decolonization with chlorhexidine and mupirocin, or universal decolonization without screening to prevent MRSA infection in intensive-care unit (ICU) patien …
REDUCE-MRSA was a 3-arm, cluster-randomized trial of either screening and isolation without decolonization, targeted decolonization with chl …
A double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of mupirocin calcium ointment for eliminating nasal carriage of Staphylococcus aureus among hospital personnel.
Fernandez C, Gaspar C, Torrellas A, Vindel A, Saez-Nieto JA, Cruzet F, Aguilar L. Fernandez C, et al. J Antimicrob Chemother. 1995 Mar;35(3):399-408. doi: 10.1093/jac/35.3.399. J Antimicrob Chemother. 1995. PMID: 7782256 Clinical Trial.
Mupirocin eliminated nasal carriage with Staphylococcus aureus in 58% of subjects within two days and 86.7% subjects by the end of therapy compared to 9.4% subjects at the end of treatment with placebo (P < 0.001). ...No resistance to mupirocin developed and the …
Mupirocin eliminated nasal carriage with Staphylococcus aureus in 58% of subjects within two days and 86.7% subjects by the end of th …
240 results